Trials / Completed
CompletedNCT05777759
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Lyft with Lidocaine | hyaluronic acid |
| DEVICE | Juvederm Voluma XC | hyaluronic acid |
Timeline
- Start date
- 2023-03-22
- Primary completion
- 2023-11-11
- Completion
- 2024-07-08
- First posted
- 2023-03-21
- Last updated
- 2025-01-17
Locations
12 sites across 2 countries: United States, Puerto Rico
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05777759. Inclusion in this directory is not an endorsement.